Preliminary studies indicate that Retatrutide – a dual agonist of gut hormone and glucose-dependent insulinotropic polypeptide receptors – offers a substantial advance in body management programs . Unlike existing treatments , the peptide seems to modify food intake and calorie burn through distinct pathways . Despite more investigation is requ